JakartaGlobe-Jan 11, 2021

The Indonesian Food and Drug Supervisory Agency, or BPOM, approved Sinovac vaccine for emergency use on Monday, making it the first coronavirus vaccine to be administered in the country. The vaccine, developed by Chinese biopharmaceutical company Sinovac Biotech, has undergone phase 3 clinical trial in the West Java capital of Bandung involving more than 1,600 volunteers. Several other countries such as Brazil and Turkey also have put the vaccine in human trials involving a much larger number of participants. “Results from the phase three clinical trial of Coronavac vaccine in Bandung demonstrate a 65.3 percent efficacy, in comparison to a 91.5 percent efficacy during a similar trial in Turkey and 78 percent in Brazil,” BPOM Head Penny Kusumastuti Lukito said in a news conference in Jakarta. She noted that the World Health Organization requires a minimum 50 percent efficacy for the use of a vaccine. Read more at: https://jakartaglobe.id/news/indonesia-approves-sinovac-vaccine-amid-dramatic-surge-in-coronavirus-cases